Ann: Appendix 4E and FY22 Preliminary Final Report, page-11

Another great announcement yesterday on the update of our Bio-chip...
What we need is now some serious investors to start taking a position in AXE rather than have this 1 step forward 2 steps back approach taken up by these trading platforms.
One point I will make is the about the 24M options (to directors and key staff) with an exercise price of $1.79 which if taken up (by 2025) will put $42M in the kitty - firstly id both hope and expect that our share price is well and truly north of $1.79 in less than 3 years time allowing these options to be taken up early which in turn avoiding any further capital raising...!